Mizuho Keeps Outperform on LifeMD and Applied Materials, Cuts AMAT Target
Mizuho maintained Outperform ratings on LifeMD and Applied Materials, and lowered the Applied Materials price target to $510 from $590, Dow Jones Newswires reports.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Dow Jones Newswires reports that Mizuho kept its Outperform rating on LifeMD shares.
Separately, the firm maintained Outperform on Applied Materials but lowered its price target to $510 from $590.
why it matters
Rating reiterations like these are routine for analysts and mostly shift sentiment around a single stock. In the Applied Materials case, the target cut alongside a positive call points to a revised valuation rather than a change in the broader view of the company.
tags
instruments
sources
- LifeMD Is Maintained at Outperform by Mizuho — Dow Jones Newswires, 13 November 2026 at 17:15 UTC
- Applied Materials Is Maintained at Outperform by Mizuho — Dow Jones Newswires, 13 November 2026 at 17:13 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗